Laboratory News and Research

RSS
Development of novel virus can lead to new therapeutic strategy to combat cancer

Development of novel virus can lead to new therapeutic strategy to combat cancer

Guardian Technologies International introduces Signature Mapping TBDx to diagnose TB

Guardian Technologies International introduces Signature Mapping TBDx to diagnose TB

ImThera Medical implants its aura6000 neurostimulation device in two OSA patients

ImThera Medical implants its aura6000 neurostimulation device in two OSA patients

Georgia Institute of Technology receives contract to design nanostructures and cognition tools

Georgia Institute of Technology receives contract to design nanostructures and cognition tools

Researchers develop new application for improved detection of breast cancer cells

Researchers develop new application for improved detection of breast cancer cells

ACMG welcomes SACGHS report on gene patenting and licensing practices

ACMG welcomes SACGHS report on gene patenting and licensing practices

Cancer Genomic Microarray Facility selects febit's Geniom RT Analyzer to advance its biomedical research

Cancer Genomic Microarray Facility selects febit's Geniom RT Analyzer to advance its biomedical research

New direct-to-consumer laboratory testing service offers streamlined access to healthcare

New direct-to-consumer laboratory testing service offers streamlined access to healthcare

New patented technology to combat healthcare-associated infections

New patented technology to combat healthcare-associated infections

Neogen announces acquisition of BioKits food safety business of San Diego

Neogen announces acquisition of BioKits food safety business of San Diego

Sperm genes may have a detrimental effect on longevity, says new study

Sperm genes may have a detrimental effect on longevity, says new study

CHS introduces the Optic onsite health care solution

CHS introduces the Optic onsite health care solution

Positive results from Ardea Biosciences' ongoing drug-drug interaction study of RDEA594 and febuxostat

Positive results from Ardea Biosciences' ongoing drug-drug interaction study of RDEA594 and febuxostat

StemCyte concludes exclusive license and commercialization agreement with Academia Sinica

StemCyte concludes exclusive license and commercialization agreement with Academia Sinica

Akonni Biosystems receives $3.2M Phase II SBIR grant from NIH

Akonni Biosystems receives $3.2M Phase II SBIR grant from NIH

TAP and pharma company team up to design Sonata, a unique system to speed drug development

TAP and pharma company team up to design Sonata, a unique system to speed drug development

WPI to develop integrated monitoring system to reduce firefighter deaths and injuries

WPI to develop integrated monitoring system to reduce firefighter deaths and injuries

DFG approves establishment of new CRCs; research topics range from modern prostheses to political reforms to marine bacteria

DFG approves establishment of new CRCs; research topics range from modern prostheses to political reforms to marine bacteria

Portuguese scientists identify a molecular mechanism that can lead to metastases in breast cancers

Portuguese scientists identify a molecular mechanism that can lead to metastases in breast cancers

Research shows link between nervous and immune systems; findings may lead to new treatments for autoimmune disorders

Research shows link between nervous and immune systems; findings may lead to new treatments for autoimmune disorders

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.